Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 23, 2025Diabetes/Metabolism Research and ReviewsOpen Access

Advancements in Pharmacotherapy for Diabetic Kidney Disease: A Systematic Review

View Full Paper
Ask AI
Bookmark
Share

Authors

HZHongli ZhangChongqing UniversityJCJiewen ChenShanghai Ninth People's HospitalNWNiansong WangShanghai Sixth People's Hospital

Discussion

Loading...

Member takes

Implication

Systematic review reveals new drugs improve renal outcomes in diabetic kidney disease, highlighting the role of multitargeted strategies.

Key Points

  • New drugs improve renal outcomes in patients with type 2 diabetes, reducing risks of end-stage renal disease.
  • Notable efficacy observed with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists.
  • Systematic review assessed advances in pharmacotherapy for diabetic kidney disease, focusing on multitarget strategies.
  • Future research should prioritize long-term safety assessments of traditional Chinese medicine and personalized therapies.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68af5bb6ad7bf08b1eadf54bhttps://doi.org/10.1002/dmrr.70077
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes2016 · 6,939 citations
  2. 2Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial2020 · 552 citations
  3. 3Empagliflozin in Patients with Chronic Kidney Disease2022 · 2,674 citations
  4. 4Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria2022 · 15 citations
  5. 5Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial2015 · 87 citations